Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-03 Sale |
2025-03-05 5:16 pm |
Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Chief Regulatory Officer |
1,059 | $6.997 | $7,410 | 18,679 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-20 6:05 pm |
Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Chief Regulatory Officer |
1,000 | $11.2 | $11,198 | 19,378 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-20 6:26 pm |
Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality |
963 | $6.6293 | $6,384 | 20,378 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 8:32 pm |
Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality |
25,750 | $0.617 | $15,888 | 529,251 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 6:16 pm |
Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality |
3,879 | $0.72 | $2,793 | 555,001 (Direct) |
View |
| 2023-11-16 Sale |
2023-11-20 5:29 pm |
Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality |
3,267 | $0.389 | $1,271 | 104,424 (Direct) |
View |
| 2023-08-16 Sale |
2023-08-18 6:25 pm |
Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality |
3,346 | $1.6532 | $5,531 | 107,691 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-08 Option Award |
2024-01-09 4:40 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality |
450,000 | $0 | 558,880 (Direct) |
View |
Ownership |
2023-06-09 4:30 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality |
0 | $0 | 353,115 (Direct) |
View |